About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:7523000
Allelic
Composition
Rtf1tm1c(KOMP)Wtsi/Rtf1tm1c(KOMP)Wtsi
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Genetic
Background
involves: C57BL/6N * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
A1cfTg(Myh6-cre/Esr1*)1Jmk mutation (5 available); any A1cf mutation (39 available)
Rtf1tm1c(KOMP)Wtsi mutation (0 available); any Rtf1 mutation (52 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice do not survive longer than 3 weeks after knockout initiation by tamoxifen (TAM) feeding

cardiovascular system
• after 3 weeks of TAM feeding, heart left ventricles (LVs) display disrupted intercalated discs with markedly reduced junctional proteins
• LVs exhibit patchy, weak N-cadherin (adherens junctions/area composita) and Connexin-43 (gap junctions) signals, suggesting altered cell-cell junctions
• after 3 weeks of TAM feeding, heart LVs exhibit more disorganized myofibrils than control LVs
• however, LVs display parallel lines of alpha-actinin staining, indicating that Z-lines of sarcomeres are intact
• after 3 weeks of TAM feeding, hearts display thinning of the ventricular walls
• after 3 weeks of TAM feeding
• after 3 weeks of TAM feeding
• after 3 weeks of TAM feeding, hearts display pronounced dilation of the left (LV) and right (RV) ventricle chambers
• after 3 weeks of TAM feeding
• after 3 weeks of TAM feeding
• after 3 weeks of TAM feeding, the LV myocardium is fibrotic with large inclusions of collagen protein in cardiomyocyte-free regions
• TAM-fed mice develop progressive left ventricular systolic dysfunction culminating in dilated cardiomyopathy and heart failure
• failing hearts exhibit gene expression changes similar to those observed in human dilated cardiomyopathy
• after 3 weeks of TAM feeding, all hearts are dilated, esp. at systole, and show severely decreased ventricular contractility with 6% FS (fractional shortening) versus 29% FS in controls
• after 2 weeks of TAM feeding, hearts show a trend of reduced left ventricular function and marked dilation, reflecting compromised contractility
• after 3 weeks of TAM feeding, ejection fraction (EF) and fractional shortening (FS) values are significantly decreased while values of LV volume at diastole and at systole are markedly increased
• however, LV contractile parameters are normal prior to TAM feeding as well as during the first week of TAM feeding
• after 3 weeks of TAM feeding, mice exhibit heart failure characterized by disrupted myofibril organization, defective intercalated disc structure, and widespread fibrosis

muscle
• after 3 weeks of TAM feeding, heart left ventricles (LVs) display disrupted intercalated discs with markedly reduced junctional proteins
• LVs exhibit patchy, weak N-cadherin (adherens junctions/area composita) and Connexin-43 (gap junctions) signals, suggesting altered cell-cell junctions
• after 3 weeks of TAM feeding, heart LVs exhibit more disorganized myofibrils than control LVs
• however, LVs display parallel lines of alpha-actinin staining, indicating that Z-lines of sarcomeres are intact
• TAM-fed mice develop progressive left ventricular systolic dysfunction culminating in dilated cardiomyopathy and heart failure
• failing hearts exhibit gene expression changes similar to those observed in human dilated cardiomyopathy
• after 3 weeks of TAM feeding, all hearts are dilated, esp. at systole, and show severely decreased ventricular contractility with 6% FS (fractional shortening) versus 29% FS in controls
• after 2 weeks of TAM feeding, hearts show a trend of reduced left ventricular function and marked dilation, reflecting compromised contractility

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy DOID:12930 OMIM:PS115200
J:338311


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory